Physician profile
Eric A Singer
NPI 1144334467
$25,011.11
in general payments reported to CMS, 2019-2025
12 companies · $6,493 in 2025
The $6,493 reported for 2025 was more than what 92% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $84.74 · 2021: $12K · 2022: $2,021 · 2024: $4,309 · 2025: $6,493.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,505 · Honoraria: $4,000 · Travel and Lodging: $767 · Food and Beverage: $530.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,504.93 |
| Honoraria | $4,000.00 |
| Travel and Lodging | $767.02 |
| Food and Beverage | $530.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $11,475.38 | 2019-2022 | |
| Ferring Pharmaceuticals INC. | $6,369.74 | 2025 | Adstiladrin |
| Urogen Pharma, INC. | $4,186.70 | 2024 | |
| Janssen Research & Development, LLC | $2,525.00 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $123.67 | 2025 | |
| Intuitive Surgical, INC. | $122.33 | 2024 | |
| Boston Scientific Corporation | $77.10 | 2019-2022 | |
| Pfizer INC. | $74.83 | 2022 | |
| Ambu INC. | $56.36 | 2021 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Singer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.